Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high ...

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...

New Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg Tablet DT 5's by the National Pharmaceutical ...

As per the USFDA, New Jersey-based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".

As per the USFDA, New Jersey based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets". New Delhi: Drug major Cipla is recalling over 1,800 boxes of ...

Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

Cipla's consolidated revenue from operations stood at ₹7,051.02 crores during the quarter ended September from ₹6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5%. The firm ...

Cipla Ltd.'s consolidated net profit rose 13% in the second quarter of the current financial year, meeting analysts' estimates. The drugmaker posted a profit of Rs 1,305.01 crore in the quarter-ended ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high... Nov ...

Cipla Limited is one of the most famous companies in India which operates in the sphere of healthcare and pharmacology; the company is the pioneer of progressive approaches to the effective treatment ...

Cipla is currently trading at Rs 1487.10, showing a 1.48% increase today, despite a weekly return of -0.46%. Cipla is currently priced at Rs 1492.60, showing a significant rise of 1.85% today. The ...